DE2625220C3 - Arzneimittel zur Behandlung von Leberkrankheiten - Google Patents

Arzneimittel zur Behandlung von Leberkrankheiten

Info

Publication number
DE2625220C3
DE2625220C3 DE2625220A DE2625220A DE2625220C3 DE 2625220 C3 DE2625220 C3 DE 2625220C3 DE 2625220 A DE2625220 A DE 2625220A DE 2625220 A DE2625220 A DE 2625220A DE 2625220 C3 DE2625220 C3 DE 2625220C3
Authority
DE
Germany
Prior art keywords
liver
administration
animals
damage
necrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2625220A
Other languages
German (de)
English (en)
Other versions
DE2625220A1 (de
DE2625220B2 (de
Inventor
Tsutomu Sakai Kasai
Hitoshi Toyonaka Kurono
Kuniaki Neyagawa Taninaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Nohyaku Co Ltd
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of DE2625220A1 publication Critical patent/DE2625220A1/de
Publication of DE2625220B2 publication Critical patent/DE2625220B2/de
Application granted granted Critical
Publication of DE2625220C3 publication Critical patent/DE2625220C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DE2625220A 1975-06-06 1976-06-04 Arzneimittel zur Behandlung von Leberkrankheiten Expired DE2625220C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/584,413 US4022907A (en) 1975-06-06 1975-06-06 Pharmaceutical compositions containing 1,3-dithiacycloalkylidene malonates

Publications (3)

Publication Number Publication Date
DE2625220A1 DE2625220A1 (de) 1976-12-23
DE2625220B2 DE2625220B2 (de) 1979-04-05
DE2625220C3 true DE2625220C3 (de) 1979-11-22

Family

ID=24337224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2625220A Expired DE2625220C3 (de) 1975-06-06 1976-06-04 Arzneimittel zur Behandlung von Leberkrankheiten

Country Status (5)

Country Link
US (1) US4022907A (https=)
JP (1) JPS51144733A (https=)
DE (1) DE2625220C3 (https=)
FR (1) FR2313041A1 (https=)
GB (1) GB1518376A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5934852A (ja) * 1982-08-19 1984-02-25 Nippon Nohyaku Co Ltd 飼料組成物
JPS6051110A (ja) * 1983-08-01 1985-03-22 Nippon Nohyaku Co Ltd 家畜のケト−ジス治療剤
DE3586541T2 (de) * 1985-05-31 1993-01-14 Banyu Pharma Co Ltd 1,3-dithiol-2-ylidenderivate.
JPS62158215A (ja) * 1985-12-28 1987-07-14 Nippon Nohyaku Co Ltd 脂肪壊死症治療剤
EP0234480A3 (en) * 1986-02-21 1988-09-14 Nihon Nohyaku Co., Ltd. 1, 3-diketone derivatives and their use
KR920005434B1 (ko) * 1988-10-27 1992-07-03 주식회사 유한양행 티오케텐 유도체와 그의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5117536B2 (https=) * 1971-02-02 1976-06-03
US3761596A (en) * 1971-02-02 1973-09-25 Nihon Nohvaku Co Ltd Fungicidal compositions containing malonic esters

Also Published As

Publication number Publication date
FR2313041B1 (https=) 1978-12-15
DE2625220A1 (de) 1976-12-23
US4022907A (en) 1977-05-10
GB1518376A (en) 1978-07-19
FR2313041A1 (fr) 1976-12-31
JPS5618578B2 (https=) 1981-04-30
DE2625220B2 (de) 1979-04-05
JPS51144733A (en) 1976-12-13

Similar Documents

Publication Publication Date Title
DE3709621A1 (de) Therapeutisches mittel
DE69031913T2 (de) Antivirale mittel
DE3511609C2 (https=)
DE2625220C3 (de) Arzneimittel zur Behandlung von Leberkrankheiten
DE2625012C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2625222C3 (de) 13-Dithiacyclopentan-2-ylidenmalonsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE68903065T2 (de) Aus gingko biloba extrahierter biologischer regulator, wirksam in verschiedenen pathologien.
DE3035688C2 (https=)
DE3779842T2 (de) Antiallergisches mittel.
EP0607777A2 (de) Verwendung von Leflunomid zur Herstellung von Interleukin 8
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2349538C2 (de) Arzneimittel zur Behandlung von Lebererkrankungen
DE3883208T2 (de) Mittel zur behandlung von keratose.
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
DE2609746A1 (de) Piperazinverbindungen sowie arzneimittel, die diese verbindungen enthalten
DE2034640C3 (de) l-p-(7-Trifluormethyl-4-chinolyl) -amino-benzoyl-piperazine, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Bluthochdruck
DE2728589C3 (de) Verwendung von 2-(2,2-disubstituierten)-Äthylimidazolinen bei der Bekämpfung von Diabetes
DE2451933C2 (https=)
DE2243777A1 (de) Dihydrochinolinderivate, ihre verwendung und verfahren zur herstellung derselben
DE2625221C3 (de) Arzneimittel zur Kontrolle von Leberkrankeiten
DE2038836C3 (de) Arzneimittel
DE2930039A1 (de) Entzuendungshemmendes mittel
DE2553101A1 (de) Arzneimittel mit hypolipaemischer wirkung
DE3333008C2 (https=)
DE2362813C3 (de) Sbeta-Cycloalkyloxy-iealpha-cyan-pregn-Sen-20-one, Verfahren zu deren Herstellung sowie diese enthaltende Mittel Syntex (U.S.A.) Inc., Palo Alto, Calif. (V.St.A.)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee